Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN117025699A reveals a chemo-enzymatic route for Larotinib intermediates. Achieve high ee values and reduced costs with scalable pharmaceutical manufacturing solutions.
Novel urea-based benzamide synthesis offers stable properties for diabetes drug research and supply chain optimization.
Novel patent CN121181646A details high-purity glycylglycylglutamine preparation offering significant supply chain reliability and cost reduction in pharmaceutical manufacturing processes.
Patent CN108276338B details a green phenylbutazone method reducing wastewater and costs. Ideal for pharmaceutical API suppliers seeking efficient manufacturing.
Novel patent CN119751416A offers safer Abemaciclib synthesis. Reduces environmental waste and improves supply chain reliability for global pharmaceutical manufacturers seeking high purity.
Novel reductive amination route for >99.99% pure ropivacaine. Eliminates resolution steps, ensuring cost-effective manufacturing and stable supply.
Patent CN108164434A reveals a safer synthesis route for Sartan intermediates. This method reduces corrosion and solvent waste, offering significant supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN103497911B reveals ChKRED20 enzyme for high-efficiency synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Advanced synthesis of pyrimidine intermediates via patent CN109467536A. Delivers high purity, scalable routes, and significant cost reduction for pharmaceutical manufacturing supply chains.
Patent CN110172078B details efficient synthesis of 19-hydroxycortodoxone derivatives. Offers cost reduction in pharmaceutical intermediate manufacturing via optimized side-chain cleavage.
Advanced palladium-catalyzed synthesis method offers high purity and cost efficiency for pharmaceutical intermediates manufacturing supply chains.
Patent CN111269132B reveals a biomimetic pyridoxal catalytic route for high-purity chiral amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106632368A reveals a scalable total synthesis route for Irinotecan Hydrochloride, ensuring high purity and supply chain stability for global API manufacturers.
Patent CN114605349B reveals a green photocatalytic method for alkyl-substituted benzothiazoles, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109942514B details a cost-effective L-phenylalanine route for Atazanavir intermediates, offering high purity and scalable manufacturing solutions.
Novel biomimetic synthesis route for Tonkinensine B offers high yield and simplified processing for reliable pharmaceutical intermediate supply chains.
Patent CN102295536B details a novel ethyl acetate-based hydrogenation process for Trimethylhydroquinone, offering superior color stability and yield for Vitamin E manufacturing.
Patent CN108484735A details solid-phase synthesis of cyclic heptapeptides. Offers high purity, scalable production, and cost-effective marine drug intermediate manufacturing solutions.
Patent CN118084740A reveals a novel synthesis route for Acetylguanidine offering high yield and purity. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN119306788A reveals high-purity impurity synthesis. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing significantly.